During the past decade, Pendleton Eye Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pendleton Eye Center" #1 sponsor was "Kala Pharmaceuticals, Inc." with 2 trials, followed by "RVL Pharmaceuticals, Inc." with 2 trials sponsored, "Formosa Pharmaceuticals, Inc." with 1 trials sponsored, "Kowa Research Institute, Inc." with 1 trials sponsored and "University of Pennsylvania" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pendleton Eye Center" #1 collaborator was "National Eye Institute (NEI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Pendleton Eye Center" are "Blepharoptosis" (2 trials), "Corneal Edema After Cataract Surgery" (1 trials), "Dry Eye" (1 trials), "Dry Eye Syndromes" (1 trials) and "Keratoconjunctivitis Sicca" (1 trials). Many other conditions were trialed in "Pendleton Eye Center" in a lesser frequency.

Most popular intervention types in "Pendleton Eye Center" are "Drug" (7 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "RVL-1201" (2 trials), "Vehicle ophthalmic solution" (2 trials), "APP13007, 0.05%" (1 trials) and "KPI-121 0.25% Ophthalmic Suspension" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pendleton Eye Center" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Pendleton Eye Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Pendleton Eye Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pendleton Eye Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".